CAS 199807-35-7

Cilengitide trifluoroacetate

CAS: 199807-35-7

Formula: C₂₉H₄₁F₃N₈O₉

Purity: 99%

Color and Shape: Solid

Molecular weight: 702.6792

Ref: IN-DA00BJ8H

2-((2S,5R,8S,11S)-5-Benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid trifluoroacetate

CAS: 199807-35-7

2-((2S,5R,8S,11S)-5-Benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid trifluoroacetate

Purity: 99%

Molecular weight: 702.69g/mol

Ref: 54-PC1007907

Cilengitide TFA

CAS: 199807-35-7

Cilengitide, αvβ3/αvβ5 inhibitor, IC50: 4.1/79 nM in vitro. 10x selectivity vs. gpIIbIIIa. Phase 2.

Formula: C₂₉H₄₁F₃N₈O₉

Color and Shape: Solid

Molecular weight: 702.68

Ref: TM-T6806

Cilengitide trifluoroacetate

CAS: 199807-35-7

Cilengitide trifluoroacetate is a cyclic pentapeptide, which is a synthetic compound originally derived from natural peptides. Its source lies in the laboratory synthesis of cyclic RGD (Arg-Gly-Asp) peptides, which are known for their ability to interact with specific integrins on cell surfaces. Cilengitide selectively targets integrin αvβ3 and αvβ5, modulating cell adhesion and signaling pathways that are crucial in tumor angiogenesis, cancer growth, and metastasis.

Formula: C₂₉H₄₁F₃N₈O₉

Purity: Min. 95%

Molecular weight: 702.68 g/mol

Ref: 3D-ZHA80735